Linked e-resources
Details
Table of Contents
Intro; Foreword; Contents; About the Editor; 1: What's New in Pathogenesis of Glaucoma; Biomechanical Theory; Vascular Theory; Neurochemical Theory; Is It Apt to Label Glaucoma, "Ocular Alzheimer's"?; Glymphatic Theory; References; 2: What's New in Structural Tests for Glaucoma; Posterior Segment OCT; Peripapillary Retinal Nerve Fiber Layer; Optic Nerve Head; Retinal Ganglion Cell Layer; Lamina Cribosa; OCT Angiography; Anterior Segment OCT; Angle Assessment; Iris Angiography; References; 3: What's New in Functional Tests for Glaucoma; Contrast Sensitivity
SPARCS (Spaeth/Richman Contrast Sensitivity)Mobile Apps; clinicCSF; Aston Contrast Sensitivity App; Perimetry; Electronic Visual Field Tests; Peristat; Visual Fields Easy (VFE); Melbourne Rapid Fields (MRF); nGoggle; Compass Perimetry; MP-3 Micoperimetry; MAIATM (Macular Integrity Assessment); Contrast Sensitivity Perimetry (CSP); Pattern Noise (PANO); Central Versus Peripheral Testing; New Strategies for Threshold Measurement; Improvements in Progression Analysis; FORUM Glaucoma Workplace; References; 4: What's New in Medical Management of Glaucoma; Existing Drugs; Prostaglandin Analogs
Macular Edema in Early Postoperative Period of Cataract Surgery and Aggravation of Inflammation in Glaucoma Patients with Uveitis: Reality or a Myth?Intraocular Inflammation; Macular Edema; Effect on Indigenous Conjunctival Flora; Chronic PGA Use and Meibomian Gland Dysfunction (MGD); Prostaglandin-Associated Periorbitopathy (PAP); Factors Related to PAP; Clicking Eyelids; Alternative Clinical Uses of Prostaglandin Analogs; Timolol; Cardiac Safety of Ophthalmic Timolol; Newer Drugs; Rho Kinase (ROCK) Inhibitors; Ripasudil; Netarsudil; Latanoprostene Bunod (LBN)
Oligonucleotide-Based CompoundsShort Interfering RNAs (siRNAs); Bamosiran; QPI-1007; Aptamers; Antisense Oligonucleotides (ASOs); Aganirsen; ISTH0036; Prostanoid Receptor Agonists; ONO-9054; Adenosine Receptor Agonists; Trabodenoson (INO-8875); Role of Statins; Sustained-Release Devices; Topical Bimatoprost Ocular Insert; Bimatoprost Intraocular Implant; Latanoprost-Eluting Contact Lens; Travoprost Intraocular Implants; ENV515; iDose; Prostaglandin Punctal Plugs; Travoprost Punctum Plug, OTX-TP; Latanoprost Punctal Plug, Latanoprost-PPDS; Injectables and Implants; Durasert; Replenish
Euclid SystemsSubconjunctival Injection of Timolol; Drugs for Ocular Surface Disease; Palmitoylethanolamide; Rebamipide; References; 5: What's New in Laser Therapy for Glaucoma; Trabeculoplasty; Selective Laser Trabeculoplasty; Newer Insights into Mechanism of Action; Technique; Pulse Duration; Number of Applications; Site of Laser Application; Same Day or Sequential SLT; Repeatability; Indications and Outcome; Primary Angle-Closure Glaucoma; Pseudoexfoliation Glaucoma (PXFG); Normal Tension Glaucoma; Uveitic Glaucoma; As Primary Therapy in Low-Resource Countries; Iris Heterochromia; Efficacy and Safety
SPARCS (Spaeth/Richman Contrast Sensitivity)Mobile Apps; clinicCSF; Aston Contrast Sensitivity App; Perimetry; Electronic Visual Field Tests; Peristat; Visual Fields Easy (VFE); Melbourne Rapid Fields (MRF); nGoggle; Compass Perimetry; MP-3 Micoperimetry; MAIATM (Macular Integrity Assessment); Contrast Sensitivity Perimetry (CSP); Pattern Noise (PANO); Central Versus Peripheral Testing; New Strategies for Threshold Measurement; Improvements in Progression Analysis; FORUM Glaucoma Workplace; References; 4: What's New in Medical Management of Glaucoma; Existing Drugs; Prostaglandin Analogs
Macular Edema in Early Postoperative Period of Cataract Surgery and Aggravation of Inflammation in Glaucoma Patients with Uveitis: Reality or a Myth?Intraocular Inflammation; Macular Edema; Effect on Indigenous Conjunctival Flora; Chronic PGA Use and Meibomian Gland Dysfunction (MGD); Prostaglandin-Associated Periorbitopathy (PAP); Factors Related to PAP; Clicking Eyelids; Alternative Clinical Uses of Prostaglandin Analogs; Timolol; Cardiac Safety of Ophthalmic Timolol; Newer Drugs; Rho Kinase (ROCK) Inhibitors; Ripasudil; Netarsudil; Latanoprostene Bunod (LBN)
Oligonucleotide-Based CompoundsShort Interfering RNAs (siRNAs); Bamosiran; QPI-1007; Aptamers; Antisense Oligonucleotides (ASOs); Aganirsen; ISTH0036; Prostanoid Receptor Agonists; ONO-9054; Adenosine Receptor Agonists; Trabodenoson (INO-8875); Role of Statins; Sustained-Release Devices; Topical Bimatoprost Ocular Insert; Bimatoprost Intraocular Implant; Latanoprost-Eluting Contact Lens; Travoprost Intraocular Implants; ENV515; iDose; Prostaglandin Punctal Plugs; Travoprost Punctum Plug, OTX-TP; Latanoprost Punctal Plug, Latanoprost-PPDS; Injectables and Implants; Durasert; Replenish
Euclid SystemsSubconjunctival Injection of Timolol; Drugs for Ocular Surface Disease; Palmitoylethanolamide; Rebamipide; References; 5: What's New in Laser Therapy for Glaucoma; Trabeculoplasty; Selective Laser Trabeculoplasty; Newer Insights into Mechanism of Action; Technique; Pulse Duration; Number of Applications; Site of Laser Application; Same Day or Sequential SLT; Repeatability; Indications and Outcome; Primary Angle-Closure Glaucoma; Pseudoexfoliation Glaucoma (PXFG); Normal Tension Glaucoma; Uveitic Glaucoma; As Primary Therapy in Low-Resource Countries; Iris Heterochromia; Efficacy and Safety